HCC Risk Biomarkers
AFP-L3 and DCP
Wako's HCC risk biomarkers AFP-L3 and DCP are intended for in vitro diagnostic use as an aid in the risk assessment of patients with chronic liver disease for development of HCC.

The serum biomarkers lectin-reactive alpha-fetoprotein (AFP-L3) and des-gamma-carboxy prothrombin (DCP) have been shown to be specific to hepatocellular carcinoma (HCC) and their combined use aids in clinical assessment for early detection. Adding the two biomarkers, AFP-L3 and DCP, to your current HCC surveillance practice can increase your chances of detecting early HCC. These tests are available now in the United States and Canada.

Cindy Mays, Key Account Manager
818-371-1799 | cynthia.mays@fujifilm.com
http://www.wakodiagnostics.com/

 

 

Blake Hicks, Key Account Executive
Office: 470-401-8438


Chat with us live - just click this link --->

We have 3 prizes for you!

• 2 Maui Jim Gift Certificates
• $500 Gift Certificate for the Allison Inn & Spa

Enter to win by clicking the entry button below and submitting your name and email address. You can enter 1 time at each vendor to improve your odds of winning. *Invalid email address entries and duplicate entries from the same showcase site will be deleted before the drawing.

Contact Fuji Film

Please enter your name.
Please enter a subject.
Please enter a valid phone number.
Please enter a message.